Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community.

25 Apr 2022

Drug-resistant mold found to be spreading and infecting susceptible people's lungs

A new study led by Imperial College London finds that drug-resistant mold is spreading from the environment and infecting susceptible people's lungs.

25 Apr 2022

Unvaccinated people threaten the safety of individuals vaccinated against SARS-CoV-2

Unvaccinated people threaten the safety of the vaccinated even when SARS-Cov-2 vaccination rates are high, according to a new modeling study published in CMAJ.

25 Apr 2022

Study finds antimicrobial resistance rates to be significantly higher during the pandemic than before

Among those hospitalized during the pandemic, both COVID-19 patients and those tested for SARS-COV-2 but negative, had higher rates of antibiotic-resistant bacterial infections compared to patients hospitalized before the pandemic, according to a study evaluating the pandemic's impact on antimicrobial resistance (AMR) in 271 hospitals across the USA, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April).

25 Apr 2022

New COVID-19 vaccine proven to be safe and effective in late-stage clinical testing

A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing.

25 Apr 2022

Accuracy and robustness of US CDC COVID-19 forecasting models

Researchers examined the accuracy of the US Centers for Disease Control and Prevention COVID-19 forecasting models.

25 Apr 2022

Treating COVID-19 using monoclonal antibodies during pregnancy

Researchers assessed the efficiency efficacy and safety of monoclonal antibodies for treating SARS-CoV-2 during pregnancy.

25 Apr 2022

Despite losing federal money, California is still testing uninsured residents for covid — for now

California is still offering free covid testing to uninsured residents even though the federal government ran out of money to pay for it.

25 Apr 2022

Vaccine effectiveness against COVID-19 infection and related hospitalization

Researchers assessed the effectiveness of COVID-19 vaccines against COVID-19 infections and related hospitalizations.

25 Apr 2022

Within-host model for the description of SARS-CoV-2 viral dynamics in the upper respiratory tract

A team of UK-based scientists has recently developed a within-host model to determine the dynamics of SARS-CoV-2 infection in the upper respiratory tract of affected individuals.

25 Apr 2022

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

T cell responses were measured to three SARS-CoV-2-associated antigens, as well as the endemic coronaviruses HCoV-OC43 and HCoV-NL63.

25 Apr 2022

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Researchers assessed factors influencing the anti-severe acute respiratory syndrome coronavirus 2 spike antibodies after SARS-CoV-2 BNT162b2 vaccination.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

A new study discussed the role of complement factor H-related protein 5 (CFHR5) in venous thromboembolism (VTE) patients and hospitalized COVID-19 patients.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Correlations between SARS-CoV-2 outcomes and cancer

Researchers analyzed SARS-CoV-2 outcomes by cancer status, treatment, type, and SARS-CoV-2 vaccination.

25 Apr 2022

The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

The study aimed to determine the impact of prior infection from SARS-CoV-2 infection on immune responses after COVID-19 vaccination in the long term.

25 Apr 2022

Prior COVID-19 protects against subsequent infections

In a recent study published in the Journal of American Medical Association (JAMA), researchers evaluated the duration and level of protection conferred by a coronavirus disease 2019 (COVID-19) infection among non-vaccinated subjects.

25 Apr 2022

Cross-reactive coronavirus antibodies might not be cross-neutralizing

In a recent study posted to Research Square* preprint server, researchers reported that cross-reactive antibodies against coronaviruses (CoVs) might not cross-neutralize all CoVs.

25 Apr 2022

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, the researchers investigated the impact of Bacillus Calmette-Guérin (BCG) vaccine-induced antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein.

25 Apr 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Drug-resistant mold found to be spreading and infecting susceptible people's lungs

Unvaccinated people threaten the safety of individuals vaccinated against SARS-CoV-2

Study finds antimicrobial resistance rates to be significantly higher during the pandemic than before

New COVID-19 vaccine proven to be safe and effective in late-stage clinical testing

Accuracy and robustness of US CDC COVID-19 forecasting models

Treating COVID-19 using monoclonal antibodies during pregnancy

Despite losing federal money, California is still testing uninsured residents for covid — for now

Vaccine effectiveness against COVID-19 infection and related hospitalization

Within-host model for the description of SARS-CoV-2 viral dynamics in the upper respiratory tract

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

The challenges of Omicron

Correlations between SARS-CoV-2 outcomes and cancer

The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

Prior COVID-19 protects against subsequent infections

Cross-reactive coronavirus antibodies might not be cross-neutralizing

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in